The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 1, 1996, Pages 404-410

  Cochrane, Charles G ^a   Revak, Susan D ^b   Merritt, T Allen ^b   Heldt, Gregory P ^b   Hallman, Mikko ^b   Cunningham, M Douglas ^b   Easa, David ^b   Pramanik, Arun ^b   Edwards, David K ^b   Alberts, Monica S ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; KL4 SURFACTANT; PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG SAFETY; GAS EXCHANGE; HUMAN; INTRATRACHEAL DRUG ADMINISTRATION; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; AGE; APGAR SCORE; ARTIFICIAL VENTILATION; BIOLOGICAL MODEL; BIRTH WEIGHT; COMPARATIVE STUDY; FEMALE; GESTATIONAL AGE; LUNG ALVEOLUS; LUNG GAS EXCHANGE; MALE; MOLECULAR GENETICS; NEONATAL RESPIRATORY DISTRESS SYNDROME; SAFETY; THORAX RADIOGRAPHY;

AGE FACTORS; AMINO ACID SEQUENCE; APGAR SCORE; BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PEPTIDES; PULMONARY ALVEOLI; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RADIOGRAPHY, THORACIC; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SAFETY;

EID: 0029664598     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.1.8542150     Document Type: Article

References (31)

1. Yu, S.-H., and F. Possmayer. 1988. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant. Biochim. Biophys. Acta 961:337-350.
2. Revak, S. D., T. A. Merritt, E. Degryse, L. Stefani, M. Courtney, M. Hallman, and C. G. Cochrane. 1988. Use of human surfactant low molecular weight apoprotein in the reconstitution of surfactant biologic activity. J. Clin. Invest. 81:826-833.
3. Curstedt, T., H. Jornvall, B. Robertson, T. Bergman, and P. Berggren. 1987. The hydrophobic low-molecular mass protein fractions of pulmonary surfactant: characterization and biophysical activity. Eur. J. Biochem. 168:255-262.
4. Sarin, V. K., S. Gupta, T. K. Leung, V. E. Taylor, B. L. Ohning, J. A. Whitsett, and J. L. Fox. 1990. Biophysical and biological activity of a synthetic 8.7 kD hydrophobic pulmonary surfactant protein SP-B. Proc. Natl. Acad. Sci. U.S.A. 87:2633-2637.
5. Nogee, L. M., D. E. de Mello, L. P. Dehner, and H. R. Colten. 1993. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N. Engl. J. Med. 328:406-410.
6. Fujita, Y., K. Kogishi, and Y. Suzuki. 1988. Pulmonary damage induced in mice by a monoclonal antibody to proteins associated with pig pulmonary surfactant. Exp. Lung. Res. 14:247-260.
7. Kobayashi, T., K. Nitta, R. Takahashi, K. Kurashima, B. Robertson, and Y. Suzuki. 1991. Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. J. Appl. Physiol. 71:530-536.
8. Robertson, B., T. Kobayashi, M. Ganzuka, G. Grossmann, W. Z. Li, and Y. Suzuki. 1991. Experimental neonatal respiratory failure induced by a monoclonal antibody to the hydrophobic surfactant-associated protein SP-B. Pediatr. Res. 30:239-243.
9. Revak, S. D., T. A. Merritt, M. Hallman, G. Heldt, R. J. La Polla, K. Hoey, R. A. Houghten, and C. G. Cochrane. 1991. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants. Pediatr. Res. 29:460-465.
10. Cochrane, C. G., and S. D. Revak. 1990. Surfactant protein SP-B(abstract). Pediatr. Res. 27:297A.
11. Cochrane, C. G., and S. D. Revak. 1991. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 254:566-568.
12. Vandenbussche, G., A. Clercx, M. Clercx, T. Curstedt, J. Johansson, H. Jornvall, and J. M. Ruysschaert. 1992. Secondary structure and orientation of the surfactant protein SP-B in a lipid environment: a Fourier transform infrared spectroscopy study. Biochemistry 31: 9169-9176.
13. Waring, A., W. Taeusch, R. Bruni, J. Amirkhanian, B. Fan, R. Stevens, and J. Young. 1989. Synthetic amphipathic sequences of surfactant protein-B mimic several physicochemical and in vivo properties of native pulmonary surfactant proteins. Peptide Res. 2:308-313.
14. Vincent, J. S., S. D. Revak, C. G. Cochrane, and I. W. Levin. 1991. Raman spectroscopic studies of model human pulmonary surfactant systems: phospholipid interactions with peptide paradigms for the surfactant protein SP-B. Biochemistry 30:8395-8401.
15. Baatz, J. E., B. Elledge, and J. A. Whitsett. 1990. Surfactant protein SP-B induces ordering at the surface of model membrane bilayers. Biochemistry 29:6714-6720.
16. Edwards, D. K. 1982. Radiology of hyaline membrane disease: transient tachypnea of the newborn and bronchopulmonary dysplasia. P. M. Farrell, editor. Lung Development: Biological and Clinical Perspectives, Vol. 2. Academic Press, Inc., New York. 47-89.
17. Toce, S. S., P. Farrell, L. Leavitt, D. Samuels, and D. Edwards. 1984. Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am. J. Dis. Child. 138:581-585.
18. Edwards, D. K., Sv. W. Hilton, T. A. Merritt, M. Hallman, F. Mannino, and B. R. Boynton. 1985. Respiratory distress syndrome treated with human surfactant: radiographic findings. Radiology 157:329-334.
19. Horbar, J. D., R. F. Soll, J. M. Sutherland, U. Kotagal, A. G. S. Philip, D. L. Kessler, G. A. Little, W. H. Edwards, D. Vidyasagar, T. N. K. Raju, A. H. Jobe, M. Ikegame, M. D. Mullett, D. Z. Myerberg, T. L. McAuliffe, and J. F. Lucey. 1989. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N. Engl. J. Med. 320:959-965.
20. Dunn, M. S., A. T. Shennan, and F. Possmayer. 1990. Single- versus multiple-dose surfactant replacement therapy in neonates of 30-36 weeks' gestation with respiratory distress syndrome. Pediatrics 86: 564-571.
21. Fujiwara, T., M. Konishi, S. Chida, K. Okuyama, Y. Ogama, Y. Takeuchi, H. Nishida, H. Kito, M. Fujimura, H. Nakamura, and T. Hashimoto for the Surfactant-TA Study Group. 1990. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. Pediatrics 86:753-764.
22. Horbar, J. D., L. Wright, R. F. Soll, E. C. Wright, A. A. Fanaroff, S. B. Korones, S. Shankaran, W. Oh, B. D. Fletcher, C. R. Bauer, J. E. Tyson, J. A. Lemons, E. F. Donovan, B. J. Stoll, D. D. Stevenson, L.-A. Papile, and J. Philips, III, for the National Institute of Child Health and Human Development Neonatal Research Network. 1993. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J. Pediatr. 123:757-766.
23. 4 surfactant improves lung function in a rat model of ARDS (abstract). Am. J. Respir. Crit. Care Med. 149:A126.
24. 4, functions like a bovine surfactant (abstract). Pediatr. Res. 37:1952A.
25. Cleary, J. P., D. C. Patel, C. Henderson, and G. P. Heldt. 1994. Positive end expiratory pressure (PEEP), lung compliance and surfactant: a comparison of KL4, Survanta (SURV) and Exosurf (Exo) in preterm rabbits (abstract). Pediatr. Res. 35:328A.
26. 4 Surfactant by some serum components (abstract). Pediatr. Res. 35:324A.
27. 4 (abstract). Pediatr. Res. 35:344A.
28. Hoekstra, R. E., J. C. Jackson, T. F. Myers, I. D. Frantz, III, M. E. Stern, W. F. Powers, M. Maurer, J. R. Raye, S. T. Carrier, J. H. Gunkel, and A. J. Gold. 1991. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 88:10-18.
29. Liechty, E. A., E. Donovan, D. Purohit, J. Gilhooly, B. Feldman, A. Noguchi, S. E. Denson, S. S. Sehgal, I. Gross, D. Stevens, M. Ikegami, R. D. Zachman, S. T. Carrier, J. H. Gunkel, and A. J. Gold. 1991. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 88:19-28.
30. Speer, C. P., B. Robertson, T. Curstedt, H. L. Halliday, D. Compagnone, O. Gefeller, K. Harms, E. Herting, G. McClure, M. Reid, R. Tubman, P. Herin, G. Noack, J. Kok, J. Koppe, L. van Sonderen, E. Laufkötter, W. Köhler, H. Boenisch, K. Albrecht, L. Haussler, M. Haim, S. B. Oetomo, A. Okken, P. C. Altfeld, P. Groneck, W. Kachel, J.-P. Relier, and H. Walti. 1992. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 89:13-20.
31. Merritt, T. A., R. F. Soil, and M. Hallman. 1993. Overview of exogenous surfactant replacement therapy. J. Intensive Care Med. 8:205-228.